Brief: Genscript Biotech Corp Says Unit Filed Form 6-K With U.S. SEC
May 14 (Reuters) - Genscript Biotech Corp 1548.HK :
* LEGEND BIOTECH COR HAS FILED A FORM 6-K WITH UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
* FROM 6-K FOR ENTRING SUBSCRIPTION DEAL FOR SALE OF
ORDINARY
SHARES & WARRANT EXERCISABLE FOR ORDINARY SHARES OF LEGEND
Source text for Eikon: ID:nHKS91t0Bq
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale